会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 24. 发明公开
    • 항동맥경화용 생약 조성물
    • 草药植物组合物
    • KR1020030093712A
    • 2003-12-11
    • KR1020020031531
    • 2002-06-05
    • 정태호권혁자정종찬
    • 정태호권혁자정종찬
    • A61K36/284A61K36/14A61K36/539
    • PURPOSE: A herbal plant composition for atherosclerosis which is harmless safety to human body without adverse effects even when administered for a long period of time is provided. Therefore, it can inhibit arteriosclerosis. CONSTITUTION: A composition for atherosclerosis contains 3 to 5 parts by weight of Atractylodis Rhizoma, 0.5 to 1.5 parts by weight of Thujae orientalis folium et ramulus, 3 to 5 parts by weight of Scutellariae Radix, 0.1 to 1 parts by weight of Poria cocos and 0.1 to 1 parts by weight of Glycyrrhizae Radix. The composition is formulated into powders, granules, capsules and tablets and orally administered in an amount of 1 to 10g per day.
    • 目的:提供动脉粥样硬化的草药植物组合物,即使长时间施用,对人体无害的安全性也不会产生不利影响。 因此,可以抑制动脉硬化。 构成:动脉粥样硬化组合物含有3〜5重量份的白术,0.5〜1.5重量份的山楂叶,3〜5重量份的黄芩,0.1〜1重量份的茯苓, 0.1〜1重量份甘草。 将组合物配制成粉末,颗粒,胶囊和片剂,并以每天1至10g的量口服。
    • 26. 发明公开
    • 브레비폴린 카르복실산을 포함하는 항 비형 간염 바이러스조성물
    • 抗乙型肝炎病毒乙型肝炎病毒组合物
    • KR1020000031971A
    • 2000-06-05
    • KR1019980048245
    • 1998-11-11
    • 윤석정종찬정태호
    • 정태호정종찬윤석
    • A61K31/35
    • PURPOSE: A pharmaceutical composition containing brevifolin carboxyl acid as an effective component is provided which has anti hepatitis B virus activity but no toxic effects. CONSTITUTION: Anti hepatitis B virus composition contains brevifolin carboxyl acid and a pharmaceutically acceptable carrier. The brevifolin carboxyl acid is a compound of formula (1) extracted from Phyllanthus urinaria and can be obtained by sephadex LH-20 column chromatography of the aqueous ethanol extract; thin membrane chromatography by using coloring reagent of FeCl3 and isolation of highly colored portion by 2 % of ethanol; and reverse phase chromatography of the isolated sample three or four times.
    • 目的:提供含有短纤维蛋白羧酸作为有效成分的药物组合物,其具有抗乙型肝炎病毒活性但无毒性作用。 构成:抗乙型肝炎病毒组合物含有短纤维蛋白羧酸和药学上可接受的载体。 短纤维素羧基酸是从小叶)提取的式(1)化合物,可通过乙醇提取物的sephadex LH-20柱色谱法得到; 通过使用FeCl3的着色试剂进行薄膜色谱分离,并将高度着色的部分分离2%的乙醇; 并分离样品的反相色谱三或四次。